Recent Posts
- Christine P. Bump to Speak at FDLI Enforcement Conference
- FDA Cannot Claim Regulatory Authority Over LDTs – But Labs Must Be Mindful, and Public Health Remains a Priority
- Opportunity for Stakeholders to Impact FDA’s “Non-Device” Software Report
- Penn Avenue Law & Policy Evaluates COVID-19 Tests for Healthcare Client
Recent Comments